Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma
Wednesday, June 19, 2013 - 20:50
in Health & Medicine
Clinical studies suggest that the novel, targeted agent ibrutinib shows real potential is a safe, effective, treatment for adults with chronic lymphocytic leukemia and for patients with mantle cell lymphoma.